Skip to main navigation Skip to search Skip to main content

ITN077AI (BEAT-MS) - A Multicenter Randomized Controlled Trial of High-Dose Immunosuppressive Therapy and Autologous Hematopoietic Stem Cell Transplant versus Best Available Approved Therapy for Treatment-Resistant Relapsing Multiple Sc.

Project: Research

Project Details

StatusFinished
Effective start/end date02/1/22 → 09/30/25

Funding

  • National Institute of Allergy & Infectious Disease: $26,056.00